MF
RPRX icon

Magnetar Financial’s Royalty Pharma RPRX Stock Holding History

Magnetar Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150,455
Closed -$5.31M – 1178
2025
Q3 		$5.31M Buy
+150,455
New +$5.45M 0.03% 226
2025
Q2 		– Sell
-161,496
Closed -$5.03M – 1114
2025
Q1 		$5.03M Buy
+161,496
New +$5.12M 0.07% 181
2023
Q1 		– Sell
-25,097
Closed -$992K – 706
2022
Q4 		$992K Buy
+25,097
New +$1.05M 0.02% 524
2022
Q2 		– Sell
-5,423
Closed -$211K – 1803
2022
Q1 		$211K Buy
+5,423
New +$213K ﹤0.01% 1049
2021
Q2 		– Sell
-75,795
Closed -$3.31M – 1356
2021
Q1 		$3.31M Buy
+75,795
New +$3.59M 0.03% 459

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Magnetar Financial's RPRX Position: Q4 2025 in Review

Magnetar Financial sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 150,455 shares — an estimated $5.31M sold.

Magnetar Financial first reported a position in RPRX in Q1 2021 and held it in 5 quarters. The position peaked at $5.31M in Q3 2025. 540 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • Magnetar Financial reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
  • Magnetar Financial sold 150,455 Royalty Pharma shares in Q4 2025, an estimated $5.31M.
  • Magnetar Financial first reported a position in Royalty Pharma in Q1 2021 and held it in 5 quarters.
  • Magnetar Financial's Royalty Pharma position peaked at $5.31M in Q3 2025.
  • 540 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on Magnetar Financial's 13F filing for Q4 2025, filed 17 Feb 2026.